Ares Systematic Credit’s Innoviva INVA Stock Holding History

Ares Systematic Credit’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,252	Closed	-$625K	–	160
2025 Q4	$625K	Buy	+31,252	New	+$610K	0.51%	66

Other funds holding INVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ares Systematic Credit's INVA Position: Q1 2026 in Review

Ares Systematic Credit sold out of Innoviva (INVA) in Q1 2026, closing a stake of 31,252 shares — an estimated $625K sold.

Ares Systematic Credit first reported a position in INVA in Q4 2025 and held it in 1 quarter. The position peaked at $625K in Q4 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

Ares Systematic Credit reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
Ares Systematic Credit sold 31,252 Innoviva shares in Q1 2026, an estimated $625K.
Ares Systematic Credit first reported a position in Innoviva in Q4 2025 and held it in 1 quarter.
Ares Systematic Credit's Innoviva position peaked at $625K in Q4 2025.
286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Ares Systematic Credit's 13F filing for Q1 2026, filed 15 May 2026.